Peter Ingraldi, MD
Surgery · Norwalk, CTNPI 1154492874
Payments from drug & device makers
Across 118 payments — averaging $37.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$904
- Organogenesis Inc.$629
- Solventum Corporation$480
- Kerecis Limited$282
- Johnson & Johnson$197
- Hydrofera LLC$189
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,388100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 38 | $904 |
| Organogenesis Inc. | 9 | $629 |
| Solventum Corporation | 11 | $480 |
| Kerecis Limited | 4 | $282 |
| Johnson & Johnson(2 entities) | 5 | $197 |
| Hydrofera LLC | 4 | $189 |
| Aroa Biosurgery Incorporated | 1 | $150 |
| Abiomed | 1 | $146 |
| Pfizer | 3 | $145 |
| W. L. Gore & Associates, Inc. | 1 | $126 |
| Davol Inc. | 2 | $126 |
| Medtronic | 2 | $97 |
| Paratek Pharmaceuticals, Inc. | 1 | $96 |
| Integra Lifesciences Corporation | 2 | $91 |
| CSL Behring | 3 | $76 |
| KCI USA, Inc. | 3 | $67 |
| Inari Medical, Inc. | 2 | $59 |
| Convatec Inc. | 2 | $46 |
| Dilon Technologies, Inc. | 1 | $46 |
| Cardiovascular Systems Inc. | 1 | $43 |
| AstraZeneca(2 entities) | 3 | $42 |
| Innocoll Pharmaceuticals Limited | 1 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Urgo Medical North America, LLC | 1 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Next Science LLC | 2 | $26 |
| Boehringer Ingelheim | 2 | $26 |
| TEI Biosciences Inc | 1 | $24 |
| Boston Scientific | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| Acell, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Teleflex LLC | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$598
- Affinity$275
- PuraPly$233
- 3M Cavilon$163
- ACTIV.A.C.$163
- V.A.C. GRANUFOAM$163
- PROMOGRAN PRISMA$163
- V.A.C. VERAFLO$163
- PURAPLY WOUND MATRIX$150
- Apligraf$150
- Kerecis Omega3 SurgiClose$149
- Impella$146
- HYDROFERA BLUE$134
- EXCLUDER Iliac Branch Endoprosthesis$126
- XARELTO$122
- ELIQUIS$108
- Phasix Mesh$106
How this compares
$4,408 in reported general payments places this provider in the 65th percentile of 289 surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Norwalk
- Craig FlochNorwalk$88K
- Neil FlochNorwalk$46K
- Mark FariesNew Haven$2.6M
- John MortonNew Haven$970K
- Joseph AferzonPortland$712K
- Adrian MaungNew Haven$584K
- Andrew DuffyNew Haven$256K
- Sherard ChiuFairfield$148K
- Nikhilesh SekharFairfield$140K
- Anees ChagparNew Haven$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.